NCT04859452View on ClinicalTrials.gov

A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

July 3, 2021

Study Completion Date

July 9, 2021

Conditions
Healthy Subjects
Interventions
DRUG

DBPR108 tablets

Drug: DBPR108, tablet, oral

DRUG

Metformin hydrochloride tablets

Drug: Metformin hydrochloride, tablet, oral

DRUG

Glibenclamide tablets

Drug: Glibenclamide, tablet, oral

DRUG

Valsartan Capsules

Drug: Valsartan, capsule, oral

DRUG

Simvastatin tablets

Drug: Simvastatin, tablet, oral

Trial Locations (1)

Unknown

First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY